Washington Trust Advisors’s Silicon Laboratories SLAB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-41
Closed -$5.38K 684
2025
Q3
$5.38K Hold
41
﹤0.01% 606
2025
Q2
$6.04K Hold
41
﹤0.01% 547
2025
Q1
$4.62K Hold
41
﹤0.01% 556
2024
Q4
$5.09K Hold
41
﹤0.01% 565
2024
Q3
$4.74K Hold
41
﹤0.01% 582
2024
Q2
$4.54K Hold
41
﹤0.01% 577
2024
Q1
$5.89K Buy
41
+11
+37% +$1.46K ﹤0.01% 548
2023
Q4
$3.97K Hold
30
﹤0.01% 594
2023
Q3
$3.48K Buy
30
+15
+100% +$2.07K ﹤0.01% 592
2023
Q2
$2.37K Hold
15
﹤0.01% 620
2023
Q1
$2.63K Hold
15
﹤0.01% 706
2022
Q4
$2.04K Sell
15
-4
-21% -$526 ﹤0.01% 725
2022
Q3
$2K Hold
19
﹤0.01% 866
2022
Q2
$3K Hold
19
﹤0.01% 840
2022
Q1
$3K Hold
19
﹤0.01% 913
2021
Q4
$4K Buy
+19
New +$3.5K ﹤0.01% 896

Other funds holding SLAB

Washington Trust Advisors's SLAB Position: Q4 2025 in Review

Washington Trust Advisors sold out of Silicon Laboratories (SLAB) in Q4 2025, closing a stake of 41 shares — an estimated $5.38K sold.

Washington Trust Advisors first reported a position in SLAB in Q4 2021 and held it in 16 quarters. The position peaked at $6.04K in Q2 2025. 325 funds tracked by Wall St. Rank hold SLAB as of Q4 2025.

  • Washington Trust Advisors reported no remaining Silicon Laboratories position as of Q4 2025 after selling out during the quarter.
  • Washington Trust Advisors sold 41 Silicon Laboratories shares in Q4 2025, an estimated $5.38K.
  • Washington Trust Advisors first reported a position in Silicon Laboratories in Q4 2021 and held it in 16 quarters.
  • Washington Trust Advisors's Silicon Laboratories position peaked at $6.04K in Q2 2025.
  • 325 funds tracked by Wall St. Rank held Silicon Laboratories as of Q4 2025.

Based on Washington Trust Advisors's 13F filing for Q4 2025, filed 3 Feb 2026.